Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) — Capital Reinvestment Ratio
Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥415.42 Million) in capital expenditures (CN¥27.09 Million). Check Shandong Weigao Orthopaedic Device Co. L tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Weigao Orthopaedic Device Co. Ltd. A Capital Reinvestment Ratio (2019–2025)
This chart tracks Shandong Weigao Orthopaedic Device Co. Ltd. A's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see 688161 operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Weigao Orthopaedic Device Co. Ltd. A from 2019 to 2025. See 688161 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥415.42 Million | CN¥27.09 Million | ▼ -26.5% |
| 2024 | 0.09x | CN¥274.19 Million | CN¥24.34 Million | ▼ -75.3% |
| 2023 | 0.36x | CN¥119.44 Million | CN¥42.98 Million | ▲ +58.1% |
| 2022 | 0.23x | CN¥508.56 Million | CN¥115.76 Million | ▲ +59.6% |
| 2021 | 0.14x | CN¥788.25 Million | CN¥112.41 Million | ▲ +85.2% |
| 2020 | 0.08x | CN¥644.12 Million | CN¥49.59 Million | ▲ +42.1% |
| 2019 | 0.05x | CN¥534.15 Million | CN¥28.94 Million | — |